Guthrie Cancer Center is a clinical research site located in Sayre, Pennsylvania, United States 18840.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Guthrie Cancer Center has participated in 3 clinical trials.
Therapeutic areas: Breast Cancer, Non-Small Cell Lung Cancer, Part 1:r/r B-cell Malignancies.
Sponsors: Novartis Pharmaceuticals, Mirati Therapeutics Inc., Beijing InnoCare Pharma Tech Co., Ltd..
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Guthrie Cancer Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Guthrie Cancer Center has 3 clinical trials on record. Their work covers Breast Cancer, Non-Small Cell Lung Cancer, Part 1:r/r B-cell Malignancies.
Guthrie Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.